期刊文献+

PEGFP-N1-CDX2真核表达质粒的构建及其在SGC-7901细胞中的表达

Construction of PEGFP-N1-CDX2 recombinant plasmid and observation of its expression in SGC-7901 cells
原文传递
导出
摘要 目的构建尾型同源盒转录因子2(CDX2)基因真核表达质粒PEGFP-N1-CDX2,并观察其在胃癌细胞中的表达。方法采用RT-PCR技术从胃癌细胞中扩增CDX2,并将PCR产物双酶切后定向克隆入PEGFP-N1的多克隆位点,构建PEGFP-N1-CDX2重组质粒。经过双酶切及测序验证后,采用阳离子聚合物转染介导将PEGFP-N1-CDX2重组质粒转染胃癌SGC-7901细胞(C组),随后实时荧光定量PCR(qRT-PCR)及Western blot检测未转染组(A组)、转染PEGFP-N1组(B组)和C组细胞CDX2的表达情况。结果重组质粒经XhoⅠ和HindⅢ双酶切和测序与CDX2基因序列一致,利用阳离子聚合物转染试剂介导将PEGFP-N1-CDX2重组质粒成功转染到胃癌SGC-7901细胞中,并获得了CDX2基因的高表达。结论成功构建PEGFP-N1-CDX2真核表达质粒,并在SGC-7901细胞内高表达。 Objective To construct the eukaryotic expression vector PEGFP-N1-CDX2 and induce the vector expression in human gastric carcinoma cells. Methods CDX2 was amplified from gastric carcinoma cell AGS by RT-PCR. The PCR products were cloned into the eukaryotic expression vector PEGFP-N1 after Xho I and Hind ]]1 digestion. Recombinant plasmid PEGFP-N1-CDX2 was identified by double enzyme digestion and DNA sequencing, and transfected into SCK;-7901 cells with cationic polymer. The expression of CDX2 in S(K;-7901 cells was identified by qRT-PCR and Western blot techniques, respectively. Results Correct construction of PEGFP-N1-CDX2 was identified by double enzyme digestion and DNA sequencing. CDX2 gene expressed by the transfected cells was testified by qRT-PCR and Western blot techniques. Conclusion The recombinant eukaryotic expression vector has been constructed successfully, which is expressed effectively in SCK2-7901 cells.
出处 《江苏医药》 CAS 北大核心 2013年第17期1996-1999,共4页 Jiangsu Medical Journal
关键词 尾型同源盒转录因子2 真核表达质粒 胃癌 CDX2 Eukaryotic expression vector Gastric carcinoma
  • 相关文献

参考文献11

  • 1蒋伟,张健锋,董丽娟,戚菁,张弘,毛振彪.人胃癌细胞株CDX2基因表达与其启动子区甲基化的关系[J].南通大学学报(医学版),2012,32(1):21-24. 被引量:4
  • 2Beck F, Chawengsaksophak K, Luckett J, ct al. A study of regional gut endoderm potency by analysis of Cdx2 null mutant chimaeric mice[J]. Dev Biol,2003,255(2):399 406.
  • 3方义湖,来茂德.结直肠肿瘤的新标记——CDX2[J].国际遗传学杂志,2006,29(4):311-316. 被引量:21
  • 4Werling RW, Yaziji H, l:mchi CE, et al. CDX2. a highly sensi- tive and specific marker of adenocarcinomas of intestinal origin: an immunohislochemical survey of 476 primary and metastatic carcinoma[J]. Am J Surg Pathol, 2003,27 (3) .. 303-4 10.
  • 5Mizoshita T, Inada K, Tsukamoto T, el al. Expression of Cdxl and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa with specialemphasis on participation in intestinal metaplasia of the human stomach[J] Gastric Cancer, 2001,4(4) : 185-191.
  • 6Mutoh H, Sakurai S, Satoh K, et al. Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice [J]. Cancer Res,2004,64(21) :7740 7747.
  • 7Yoshida D,Watanabe K, Noha M, et al. Ant:invasive effect of an anti matrix metalloproteinase agent in a murine brain slice model using the serial monitoring of green fluorescent protein-labeled glioma cells[J ]. Neurosurgery, 2003,52 (1) : 187-197.
  • 8Tao W, Evans BG, Yao J, et al. Enhanced green fluorescent protein is a nearly ideal long-term expression tracer for hema- topoietic stem cells, whereas DsRed-express fluorescent protein is not[J]. Stem Cells, 2007,25 (3) .. 670-678.
  • 9Ueta Y, Fujihara H, Serino R, et al. Transgenic expression of enhanced green fluorescent protein enables direct visualization for physiological studies of vasopressin neurons and isolated nerve terminals of the rat[J]. Endocrinology, 2005,146 (1) : 406-413.
  • 10Vitriol EA, Uetreeht AC, Shen F, et al. Enhanced EGFP- chromophore-assisted laser inactivation using deficient ceils rescued with functional EGFP-fusion proteins [J]. Proc Natl Acad Sei USA, 2007,104 (16) : 6702-6707.

二级参考文献42

  • 1Lorentz O,Duluc I,Arcangelis AD,et al.Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation[J].J Cell Biol,1997,139(6):1553-1565.
  • 2Liu Q,Teh M,Ito K,et al.CDX2 expression is progressively decreased in human gastric intestinal metaplasia,dysplasia and cancer[J].Mod Pathol,2007,20(12):1286-1297.
  • 3Xie Y,Li L,Wang X,et al.Overexpression of CDX2 inhibits progression of gastric cancer in vitro[J].Int J Oncol,2010,36(2):509-516.
  • 4Bird A.Perceptions of epigenetics[J].Nature,2007,447(7143):396-398.
  • 5Momparler RL.Cancer epigenetics[J].Oncogene,2003,22(42):6479-6483.
  • 6Turek-Plewa J,Jagodzinski PP.The role of mammalian DNA methyltransferases in the regulation of gene expression[J].Cell Mol Biol Lett,2005,10(4):631-647.
  • 7Brown R,Plumb JA.Demethylation of DNA by decitabine in cancer chemotherapy[J].Expert Rev Anticancer Ther,2004,4(4):501-510.
  • 8Esteller M.Relevance of DNA methylation in the management of cancer[J].Lancet Oncol,2003,4(6):351-358.
  • 9Lyko F,Brown R.DNA methyltransferences inhibitors and the development of epigenetic cancer therapies[J].J Natl Cancer Inst,2005,97(20):1498-1506.
  • 10Zhu WG,Hileman T,Ke Y,et al.5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation[J].J Biol Chem,2004,279(15):15161-15166.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部